Bo Yu

机构：Nanchang University, Harbin Medical University, China Pharmaceutical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Huadong Hospital, Second Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-7257-2855

发表论文 140 篇 · 总被引 4905 次 · h-index 36

代表论文

• SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm (2024 · Journal of Clinical Investigation · 被引 47)
• Antiferroptosis therapy alleviated the development of atherosclerosis (2024 · MedComm · 被引 23)
• ACSL1 Aggravates Thromboinflammation by LPC/LPA Metabolic Axis in Hyperlipidemia Associated Myocardial Ischemia‐Reperfusion Injury (2025 · Advanced Science · 被引 19)
• HINT1 aggravates aortic aneurysm by targeting ITGA6/FAK axis in vascular smooth muscle cells (2025 · Journal of Clinical Investigation · 被引 10)
• Association between health insurance cost-sharing and choice of hospital tier for cardiovascular diseases in China: a prospective cohort study (2024 · The Lancet Regional Health - Western Pacific · 被引 10)
• A Di-aptamer-functionalized scaffold promotes bone regeneration by facilitating the selective retention of MSCs and EPCs and then promoting crosstalk between osteogenesis and angiogenesis (2025 · Biomaterials · 被引 8)